亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study

医学 肿瘤科 癌症 内科学 危险系数 比例危险模型 头颈部癌 癌症分期 阶段(地层学) 队列 置信区间 生物 古生物学
作者
Brian O’Sullivan,Shao Hui Huang,Jie Su,Adam S. Garden,Erich M. Sturgis,Li Xu,Nancy Y. Lee,Nadeem Riaz,Xin Pei,Shlomo A. Koyfman,David J. Adelstein,Brian B. Burkey,Jeppe Friborg,Claus Andrup Kristensen,Anita Gothelf,Frank Hoebers,B. Kremer,Ernst‐Jan M. Speel,Daniel W. Bowles,David Raben,Sana D. Karam,Eugene Yu,Wei Xu
出处
期刊:Lancet Oncology [Elsevier BV]
卷期号:17 (4): 440-451 被引量:631
标识
DOI:10.1016/s1470-2045(15)00560-4
摘要

Human papillomavirus-related (HPV+) oropharyngeal cancer is a rapidly emerging disease with generally good prognosis. Many prognostic algorithms for oropharyngeal cancer incorporate HPV status as a stratification factor, rather than recognising the uniqueness of HPV+ disease. The International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S) aimed to develop a TNM classification specific to HPV+ oropharyngeal cancer.The ICON-S study included patients with non-metastatic oropharyngeal cancer from seven cancer centres located across Europe and North America; one centre comprised the training cohort and six formed the validation cohorts. We ascertained patients' HPV status with p16 staining or in-situ hybridisation. We compared overall survival at 5 years between training and validation cohorts according to 7th edition TNM classifications and HPV status. We used recursive partitioning analysis (RPA) and adjusted hazard ratio (AHR) modelling methods to derive new staging classifications for HPV+ oropharyngeal cancer. Recent hypotheses concerning the effect of lower neck lymph nodes and number of lymph nodes were also investigated in an exploratory training cohort to assess relevance within the ICON-S classification.Of 1907 patients with HPV+ oropharyngeal cancer, 661 (35%) were recruited at the training centre and 1246 (65%) were enrolled at the validation centres. 5-year overall survival was similar for 7th edition TNM stage I, II, III, and IVA (respectively; 88% [95% CI 74-100]; 82% [71-95]; 84% [79-89]; and 81% [79-83]; global p=0·25) but was lower for stage IVB (60% [53-68]; p<0·0001). 5-year overall survival did not differ among N0 (80% [95% CI 73-87]), N1-N2a (87% [83-90]), and N2b (83% [80-86]) subsets, but was significantly lower for those with N3 disease (59% [51-69]; p<0·0001). Stage classifications derived by RPA and AHR models were ranked according to survival performance, and AHR-New was ranked first, followed by AHR-Orig, RPA, and 7th edition TNM. AHR-New was selected as the proposed ICON-S stage classification. Because 5-year overall survival was similar for patients classed as T4a and T4b, T4 is no longer subdivided in the re-termed ICON-S T categories. Since 5-year overall survival was similar among N1, N2a, and N2b, we re-termed the 7th edition N categories as follows: ICON-S N0, no lymph nodes; ICON-S N1, ipsilateral lymph nodes; ICON-S N2, bilateral or contralateral lymph nodes; and ICON-S N3, lymph nodes larger than 6 cm. This resembles the N classification of nasopharyngeal carcinoma but without a lower neck lymph node variable. The proposed ICON-S classification is stage I (T1-T2N0-N1), stage II (T1-T2N2 or T3N0-N2), and stage III (T4 or N3). Metastatic disease (M1) is classified as ICON-S stage IV. In an exploratory training cohort (n=702), lower lymph node neck involvement had a significant effect on survival in ICON-S stage III but had no effect in ICON-S stage I and II and was not significant as an independent factor. Overall survival was similar for patients with fewer than five lymph nodes and those with five or more lymph nodes, within all ICON-S stages.Our proposed ICON-S staging system for HPV+ oropharyngeal cancer is suitable for the 8th edition of the Union for International Cancer Control/American Joint Committee on Cancer TNM classification. Future work is needed to ascertain whether T and N categories should be further refined and whether non-anatomical factors might augment the full classification.None.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
6秒前
集典完成签到 ,获得积分10
8秒前
Ultraman45发布了新的文献求助10
11秒前
Ultraman45发布了新的文献求助10
22秒前
23秒前
量子星尘发布了新的文献求助10
27秒前
28秒前
Ultraman45完成签到,获得积分10
29秒前
NexusExplorer应助江洋大盗采纳,获得10
30秒前
meow完成签到 ,获得积分10
35秒前
情怀应助lf采纳,获得10
37秒前
46秒前
47秒前
hta_chen完成签到,获得积分10
47秒前
lf发布了新的文献求助10
50秒前
hta_chen发布了新的文献求助10
52秒前
56秒前
Zhy发布了新的文献求助10
59秒前
李健的小迷弟应助He采纳,获得20
59秒前
繁荣的青旋完成签到,获得积分10
1分钟前
1分钟前
1分钟前
嘟嘟嘟嘟完成签到 ,获得积分10
1分钟前
Zhy完成签到,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
1分钟前
lf发布了新的文献求助10
1分钟前
lei029发布了新的文献求助10
1分钟前
1分钟前
1分钟前
Tonyzad完成签到,获得积分10
1分钟前
He发布了新的文献求助20
1分钟前
江洋大盗发布了新的文献求助10
1分钟前
CATH完成签到 ,获得积分10
1分钟前
lei029完成签到,获得积分10
2分钟前
kingJames发布了新的文献求助10
2分钟前
kingJames完成签到,获得积分10
2分钟前
慕青应助555557采纳,获得10
2分钟前
迷路的八宝粥完成签到,获得积分10
2分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976619
求助须知:如何正确求助?哪些是违规求助? 3520720
关于积分的说明 11204567
捐赠科研通 3257359
什么是DOI,文献DOI怎么找? 1798716
邀请新用户注册赠送积分活动 877897
科研通“疑难数据库(出版商)”最低求助积分说明 806613